The Use of National Cancer Registry Data for Breast Cancer Family History Assessment in Premenopausal Women

被引:0
作者
Chodick, Gabriel [1 ,2 ]
Silverman, Barbara G. [1 ,2 ]
Keinan-Boker, Lital [2 ,3 ]
机构
[1] Tel Aviv Univ, Sch Publ Hlth, IL-6997801 Tel Aviv, Israel
[2] Minist Hlth, Israel Ctr Dis Control, Israel Natl Canc Registry, IL-5262000 Tel Hashomer, Israel
[3] Univ Haifa, Sch Publ Hlth, IL-3498838 Haifa, Israel
关键词
breast cancer; BRCA; family history; Israel; OVARIAN-CANCER; BRCA1; RISK; MUTATIONS; ISRAEL;
D O I
10.3390/jcm13154473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Population-based cancer registries are the best source of information to measure cancer burden. However, little is done to use this information for individual cancer risk assessment. In this study, we aimed at identifying women at high risk of breast and ovarian cancer using data on family history of cancer from the Israel national cancer registry. Methods: We used the family history assessment tool (FHAT) to score all females, 26 to 45 years of age, in a 2.6-million-member health provider in Israel (Maccabi Healthcare Services). Data on breast, ovarian, prostate, and pancreatic cancer history among the participants and their parents (identified using the national census) were retrieved from the national cancer registry. These data were used to calculate individual FHAT scores. Results: A total of 377,931 eligible women were included in the analysis. A relevant family history of cancer was detected in 20,386 (5.4%), with FHAT scores ranging from 1 to 16. FHAT score was higher in older women and among those with a history of breast cancer. Among women aged 35-39, an FHAT score of 10 or above was associated with an OR of 15.23 (95%CI: 7.41-28.19) for breast cancer compared to women with an FHAT of 0. Conclusions: Using individual-level data from national cancer registries may assist in detecting women with a relevant family history of cancer.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions
    Allweis, Tanir M.
    Hermann, Naama
    Berenstein-Molho, Rinat
    Guindy, Michal
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4306 - 4317
  • [2] National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
    Childers, Christopher P.
    Childers, Kimberly K.
    Maggard-Gibbons, Melinda
    Macinko, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3800 - +
  • [3] The association between age at breast cancer diagnosis and prevalence of pathogenic variants
    Daly, Mary B.
    Rosenthal, Eric
    Cummings, Shelly
    Bernhisel, Ryan
    Kidd, John
    Hughes, Elisha
    Gutin, Alexander
    Meek, Stephanie
    Slavin, Thomas P.
    Kurian, Allison W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (03) : 617 - 626
  • [4] Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer
    Del Fiol, Guilherme
    Kohlmann, Wendy
    Bradshaw, Richard L.
    Weir, Charlene R.
    Flynn, Michael
    Hess, Rachel
    Schiffman, Joshua D.
    Nanjo, Claude
    Kawamoto, Kensaku
    [J]. JCO CLINICAL CANCER INFORMATICS, 2020, 4 : 1 - 9
  • [5] Family history intake: a challenge to personalized approaches in health promotion and disease prevention
    Endevelt, Ronit
    Goren, Iris
    Sela, Tal
    Shalev, Varda
    [J]. ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2015, 4
  • [6] Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987-2016
    Everatt, Ruta
    Intaite, Birute
    [J]. MEDICINA-LITHUANIA, 2020, 56 (07): : 1 - 8
  • [7] Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
    Gabai-Kapara, Efrat
    Lahad, Amnon
    Kaufman, Bella
    Friedman, Eitan
    Segev, Shlomo
    Renbaum, Paul
    Beeri, Rachel
    Gal, Moran
    Grinshpun-Cohen, Julia
    Djemal, Karen
    Mandell, Jessica B.
    Lee, Ming K.
    Beller, Uziel
    Catane, Raphael
    King, Mary-Claire
    Levy-Lahad, Ephrat
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (39) : 14205 - 14210
  • [8] A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center
    Gilpin, CA
    Carson, N
    Hunter, AGW
    [J]. CLINICAL GENETICS, 2000, 58 (04) : 299 - 308
  • [9] Greenberg Rotem, 2023, Genet Med Open, V1, P100824, DOI 10.1016/j.gimo.2023.100824
  • [10] Israeli Ministy of Health, 2023, Ministry of Health's Data on Breast Cancer in Israel for the Year 2020